ContractLicense Agreement • November 9th, 2007 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Ontario
NOTE: CERTAIN CONFIDENTIAL INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT AND REPLACED BY “[*]”. A COMPLETE COPY OF THIS DOCUMENT INCLUDING THE CONFIDENTIAL INFORMATION HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
ContractDistribution and License Agreement • November 9th, 2007 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances)
NOTE: CERTAIN CONFIDENTIAL INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT AND REPLACED BY “[*]”. A COMPLETE COPY OF THIS DOCUMENT INCLUDING THE CONFIDENTIAL INFORMATION HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
LICENSE AGREEMENTLicense Agreement • November 9th, 2007 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
THIS LICENSE AGREEMENT (the “Agreement”) is made and entered into as of July 2, 2007 (the “Effective Date”), by and between NPS ALLELIX CORP. (“NPS”), with a business address of MaRS Centre, 101 College Street, South Tower, Suite 800, Toronto, ON MSG 1L8 Canada, and Nycomed Danmark ApS (“Nycomed”), company registration number CVR 16406899, located at Langebjerg 1, 4000 Roskilde, Denmark. NPS and Nycomed are referred to in this Agreement individually as a “Party” and collectively as “Parties.”
DISTRIBUTION AND LICENSE AGREEMENT BY AND BETWEEN NPS ALLELIX CORP. NPS PHARMACEUTICALS, INC. AND NYCOMED GmbH DATED SEPTEMBER 24, 2007Distribution and License Agreement • November 9th, 2007 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Distribution and License Agreement (this “Agreement”) is made and effective as of the 24th day of September, 2007 (the “Effective Date”) by and between NPS Allelix Corp., a Canadian corporation (“NPS Allelix”), having offices at MaRS Centre, 101 College Street, South Tower, Suite 800, Toronto, ON MSG 1L8 Canada, NPS Pharmaceuticals, Inc., a Delaware corporation (“NPS US”, and, together with NPS Allelix, collectively, “NPS”), having offices at Morris Corporate Center 1, 4th Floor, Building B, 300 Interpace Parkway, Parsippany, NJ 07054, and Nycomed GmbH, a German corporation with company registration number Hrb Nr 701257 (“Nycomed”), having offices at Byk Gulden Str. 2, 78467 Konstanz.
AGREEMENT FOR SALE AND ASSIGNMENT OF RIGHTS NPS PHARMACEUTICALS, INC., NPS ALLELIX CORP. - and - DRUG ROYALTY L.P. 3Agreement for Sale and Assignment of Rights • November 9th, 2007 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
WHEREAS capitalized terms used and not otherwise defined in the following recitals have the meanings specified in Section 1.1;
